Under construction – not a live service
Sign in
Not yet taking people in KenyaNo phase

TelePharm PrEP/PEP

Key facts

Where
Kisumu, KenyaSee the site

Where in Kenya

  • Kenya Medical Research InstituteKisumu, KenyaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fred Hutchinson Cancer Center
Trial code
NCT07561658
Record updated
11 May 2026
Original description
In this study, the investigators will evaluate whether introducing a remote nurse to screen, counsel, and guide clients through HIV self-testing (via a telehealth platform) and support interested clients (via SMS) between pharmacy visits increases PrEP/PEP initiations and continuation compared to standard PrEP/PEP delivery by pharmacy providers. The investigators hypothesize that pharmacy PrEP/PEP services delivered with telehealth support will result in better service utilization and implementation outcomes compared to standard delivery and be cost-effective to implement.Read full original descriptionShow less

Leveraging Telehealth to Optimize PrEP and PEP Delivery at Pharmacies in Kenya

In this study, the investigators will evaluate whether introducing a remote nurse to screen, counsel, and guide clients through HIV self-testing (via a telehealth platform) and support interested clients (via SMS) between pharmacy visits increases PrEP/PEP initiations and continuation compared to standard PrEP/PEP delivery by pharmacy providers. The investigators hypothesize that pharmacy PrEP/PEP services delivered with telehealth support will result in better service utilization and implementation outcomes compared to standard delivery and be cost-effective to implement.

Inclusion: Pharmacies; Registered with the Pharmacy and Poisons Board (PPB); Must have at least one full-time licensed pharmacist or pharmaceutical technologist on staff; Must have a private room where HIV testing and PrEP/PEP counseling can occur; >3 km from other study pharmacies; Willing to participate in research activities, including 2-day training for pharmacy providers; Willing to share pharmacy records with us; Sells HIVST kits that are WHO certified; Pharmacists/remote nurses; ≥ 18 years old; Licensed pharmacist, pharmaceutical technologist, or nurse; Willing to provide PrEP and PEP services, including HIV testing and associated counseling services; Willing to complete training on PEP/PrEP service delivery at pharmacies, including certification for rapid diagnostic testing; Able and willing to provide informed consent; Clients; ≥ 15 years old; Interested in being screened for PrEP or PEP; Meets all criteria to be eligible for pharmacy-delivered PrEP or PEP on the Prescribing Checklist, including being at risk for HIV and not having any medical conditions that might contraindicate PrEP/PEP safety; Able and willing to provide informed consent.

Exclusion: Currently enrolled in any other HIV vaccine or prevention trial; Have a condition that would preclude provision of informed consent, make study participation unsafe, complicate interpretation of outcome data, or otherwise interfere with achieving study objectives; Clients; Unwilling to provide a phone number at which an RA can reach them for completing surveys and communicate important study-related information.

ClinicalTrials.gov NCT07561658